Received Aug 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | G75S4 | — |
Expired vaccine used/expired on 05 Jul 2025; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 67-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number G75S4, expiry date 05-JUL-2025) for prophylaxis. On 24-JUL-2025, the patient received Arexvy. On 24-JUL-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: Expired vaccine used/expired on 05 Jul 2025). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 25-JUL-2025 The pharmacist called to inform gave an Arexvy vaccine to a patient and realize after giving it that the antigen component of the vaccine expiration date was 05 Jul 2025 which led to Expired vaccine used, checked the adjuvant, and it was in date. According to reporter, the dose was given on 24 Jul 2025.